In a move that underscores its bullish stance on the future of specialist insurance, private equity investor B.P. Marsh announced Monday that it has acquired an additional 2% interest in Pantheon Specialty for £5.5 million ($7.5 million). The transaction boosts its total stake in the Lloyd’s market broker to a commanding 39%.
The stake was purchased from Pantheon’s co-founders, Robert Dowman and Michael Lee, and was fully funded through B.P. Marsh’s internal cash reserves — a clear signal of conviction in Pantheon’s growth momentum. The deal, which values Pantheon at £275 million, required no regulatory approval.
Financing for Expansion, Confidence for the Future
As part of the arrangement, B.P. Marsh has also committed a £5 million loan, with £3.5 million set to be drawn down immediately upon deal completion. The funds will give Pantheon the financial agility needed to maintain its upward trajectory, the firm said in a statement.
“This deal reinforces our confidence in Pantheon’s future growth prospects,” B.P. Marsh stated, adding that the combination of equity and debt demonstrates a long-term partnership model.
